Laboratory record
SGS
Biopharmaceutical characterisation across a large multi-site network, including peptide mapping, amino acid sequencing and analysis, N- and C-terminal sequencing, molecular weight determination, impurity identification, and size-exclusion, reversed-phase, HILIC and ion-exchange chromatography.
Baar, Zug, Switzerland
Published capabilities
Recorded from the laboratory’s own live pages. “Not stated” means the laboratory has not published a position — it is not a statement that the service is unavailable.
- Peptide-specific testing
- Yes
- HPLC
- Yes
- LC-MS
- Not stated
- Mass spectrometry
- Yes
- Identity
- Yes
- Purity
- Yes
- Amino acid analysis
- Yes
- Endotoxin
- Not stated
- Sterility
- Not stated
Accreditation and working terms
- Accreditation
- Self-reported: “A full package of biopharmaceutical characterization services to GLP/cGMP standards”, with methods available to GMP and aligned to ICH Q6B.Self-reported
- Turnaround time
- Not publicly stated
- Sample requirements
- Not publicly stated
- Report policy
- Not publicly stated — contract model, reports to the client.
Sources
- SGS — biopharmaceutical product characterizationCapabilities and quality claims read from the live page on 3 September 2026.
Last reviewed 3 September 2026 · Report an inaccuracy in this record